A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Icu Medical Inc stock. As of the latest transaction made, Bridgewater Associates, LP holds 4,624 shares of ICUI stock, worth $491,716. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,624
Previous 22,534 79.48%
Holding current value
$491,716
Previous $2.25 Million 77.93%
% of portfolio
0.0%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$86.88 - $112.48 $1.56 Million - $2.01 Million
-17,910 Reduced 79.48%
4,624 $496,000
Q4 2023

Feb 14, 2024

BUY
$81.08 - $119.29 $1.44 Million - $2.12 Million
17,769 Added 372.91%
22,534 $2.25 Million
Q3 2023

Nov 13, 2023

SELL
$115.27 - $182.23 $1.86 Million - $2.93 Million
-16,095 Reduced 77.16%
4,765 $567,000
Q2 2023

Aug 11, 2023

SELL
$161.03 - $209.15 $762,638 - $990,534
-4,736 Reduced 18.5%
20,860 $3.72 Million
Q1 2023

May 12, 2023

BUY
$153.15 - $198.21 $248,562 - $321,694
1,623 Added 6.77%
25,596 $4.22 Million
Q4 2022

Feb 13, 2023

SELL
$136.25 - $165.56 $1.02 Million - $1.24 Million
-7,493 Reduced 23.81%
23,973 $3.78 Million
Q3 2022

Nov 10, 2022

BUY
$149.44 - $188.1 $4.7 Million - $5.92 Million
31,466 New
31,466 $4.74 Million
Q2 2022

Aug 11, 2022

SELL
$161.4 - $229.7 $5.22 Million - $7.44 Million
-32,369 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$203.51 - $247.46 $2.09 Million - $2.54 Million
10,282 Added 46.55%
32,369 $7.21 Million
Q4 2021

Feb 14, 2022

BUY
$220.96 - $247.44 $551,516 - $617,610
2,496 Added 12.74%
22,087 $5.24 Million
Q3 2021

Nov 12, 2021

SELL
$186.8 - $260.0 $321,482 - $447,460
-1,721 Reduced 8.08%
19,591 $4.57 Million
Q2 2021

Aug 13, 2021

BUY
$190.83 - $215.73 $4.07 Million - $4.6 Million
21,312 New
21,312 $4.39 Million

Others Institutions Holding ICUI

About ICU MEDICAL INC


  • Ticker ICUI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 23,899,400
  • Market Cap $2.54B
  • Description
  • ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and Swa...
More about ICUI
Track Ray Dalio's Portfolio

Track Ray Dalio Portfolio

Follow Ray Dalio (Bridgewater Associates, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.